Colleran David

EVP, General Counsel, Corp SecAnika Therapeutics, Inc. (ANIK) · full profile →Form 4 · filed May 12, 2022
Net Buying
Open-Market Buys
$32K
Open-Market Sells
$0
Net Open-Market Flow
$32K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 11, 2022Buy(P)2K$21.37$32K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001171843-22-003615) within minutes of acceptance. Every field above traces to the original document. Verify it directly: